Visit from the Minister of the Economy and Innovation
On September 2021, the Minister of the Economy and Innovation of the Republic of Lithuania Aušrinė Armonaitė visited the office of Inovatyvi Medicina. We had
August 26, 2021
Sentante enables the remote manipulation of catheters and guidewires
for safe and rapid endovascular disease management
Remote interventions reduce the response time for
stroke, heart attack
and bleeding
Uniqueness
of Sentante:
of Sentante:
Disruptive technology:
01
Fully robotic
The manipulation of three endovascular intstruments simultaneously allows the entire procedure to be performed robotically.
02
Teleoperated
The endovascular procedure can be performed from a different room or hospital.
03
Haptic feedback
Physicians can feel the catheter and guidewire just as if they were standing near the patient
04
Universal compatibility
A variety of dedicated catheters and guidewires are compatible, with no dependence on the manufacturer
05
Precise manipulation
Accurate, submillimetric instrument positioning and stent placement
06
Ergonomic workplace
Allows physicians to fully concentrate on an ongoing case without the use of heavy lead aprons
07
No additional training is needed
Medical personnel are not exposed to hazardous X-rays
08
Occupational hazards free
Medical personnel are not exposed to hazardous X-rays
Future
perspectives
perspectives
01
Training module
Realistic training platform with haptic feedback for residents and new physicians
02
Device testing platform
Simulated models for safe, affordable testing and training of endovascular devices
03
Artificial intelligence based automation
Semi-automated routine tasks such as catheter or guidewire exchange
About Us
Our vision is to transform healthcare by increasing treatment availability for patients and protecting medical personnel from occupational hazard. Our mission is to bring the world’s first fully-robotic system for endovascular interventions to clinical practice for the benefit of patients, physicians, and hospitals.
Our values People focused. We care about patients, medical personnel, and colleagues. Result-based. We are bringing only evidence-based, new medical solutions to the hospitals.
Innovation driven. Constant research and development of the novel medical solutions. Sustainability in mind. Trying not to destroy the planet while supplying the most advanced healthcare solutions.
Our vision is to transform healthcare by increasing treatment availability for patients and protecting medical personnel from occupational hazard. Our mission is to bring the world’s first fully-robotic system for endovascular interventions to clinical practice for the benefit of patients, physicians, and hospitals.
Our values People focused. We care about patients, medical personnel, and colleagues. Result-based. We are bringing only evidence-based, new medical solutions to the hospitals.
Innovation driven. Constant research and development of the novel medical solutions. Sustainability in mind. Trying not to destroy the planet while supplying the most advanced healthcare solutions.
Team
Tomas Baltrūnas
CMO
Vascular surgeon, founder of Inovatyvi Medicina
Edvardas Satkauskas
CEO
Experienced entrepreneur, Co-founder of Inovatyvi Medicina
Dr. Evaldas Kalvaitis
Head of regulatory affairs
Co-founder of Inovatyvi Medicina
Vilius Dambrauskas
CTO
Co-founder of Inovatyvi Medicina
Vaidas Labunskas
Chief mechanical engineer
Co-founder of Inovatyvi Medicina
Andrius Karaliūnas
Mechanical engineer
Arminas Jatkauskas
Mechanical engineer
Eividas Kavolėlis
Electronic engineer
Giedrius Kerezis
Mechanical engineer
Linas Tiškus
Electronic engineer
Gintas Milčius
Mechanical engineer
Paulius Juostas
Mechanical engineer
Remigijus Grišius
Mechanical engineer
Romas Petkus
Electronic engineer
Benas Beklešovas
Regulatory affairs specialist
Route to
market
market
Expecting launch in 2024
01
Inovatyvi Medicina established
Sentante development began
02
First grant received
Lithuanian Business support agency
01
Hard, dedicated work
TRL4 reached
02
H2020 SME phI grant
Awarded a highly competitive grant
03
Perfect New Year’s party
A solid kickstart into 2019
01
First animal test
Proved to manipulate guidewires perfectly
02
TRL4 reached
Positive feedback from physicians
01
Ongoing animal tests
Again, proved to manipulate guidewires and catheters perfectly
02
TRL5 reached
03
First patent application
EPO
01
TRL6 reached
02
Successful stent implantation
Both Rx and OTW
03
First patent application
01
Expected first in human procedure
02
First patent application
Perry Van Rijsingen joins the Board of Inovatyvi Medicina
We have had the absolute honor and pleasure of welcoming Perry Van Rijsingen to the Board of Inovatyvi Medicina.Perry Van Rijsingen studied Biomedical Physics at
August 2, 2021
Inovatyvi Medicina mentioned by European Commission
We have had the great privilege to have been mentioned by the European Commision, which took note of our multidisciplinary team and work here at
June 6, 2020
